Tech Company Financing Transactions
Choose Ketamine Funding Round
On 2/6/2023, Choose Ketamine announced Seed investment from Notley Ventures and Manifestations Capital.
Transaction Overview
Company Name
Announced On
2/6/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Notley Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its presence into 50 states and to grow its team of expert clinical providers and trained psychedelic guides.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
106 E 6th St, Unit 900,
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Website
Email Address
Overview
Choose Ketamine is a wellness platform that connects patients with psychiatric medical practices that can provide at home ketamine therapy. The Choose Ketamine platform is overseen by an advisory team of certified medical experts that have experience with psychedelic medicine and behavioral health. Choose Ketamine's mission is to provide evidence-based, patient-first medical care to those who suffer from mental health disorders by making at-home ketamine treatment options available to more people.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Holland
Chief Operating Officer
Robert Lee
Browse more venture capital transactions:
Prev: 2/6/2023: Olokun Minerals venture capital transaction
Next: 2/6/2023: Latent Technology venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs